|
Enrolling by invitation
|
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A |
|
Recruiting
|
NCT05755997 -
CERebrolysin In CADASIL
|
Phase 2 |
|
Recruiting
|
NCT06148051 -
AusCADASIL: An Australian Cohort of CADASIL
|
|
|
Recruiting
|
NCT04310098 -
CADASIL Registry Study
|
|
|
Completed
|
NCT01114815 -
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
|
N/A |
|
Recruiting
|
NCT05677880 -
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
|
|
|
Recruiting
|
NCT02795052 -
Neurologic Stem Cell Treatment Study
|
N/A |
|
Completed
|
NCT02837354 -
The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage?
|
N/A |
|
Recruiting
|
NCT01361763 -
Safety Study of Dabigatran in CADASIL
|
Phase 2 |
|
Completed
|
NCT06072118 -
Adrenomedullin for CADASIL
|
Phase 2 |
|
Active, not recruiting
|
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
|
|
Recruiting
|
NCT05473637 -
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
|
|
|
Enrolling by invitation
|
NCT02032225 -
Generation of a Cellular Model of CADASIL From Skin Fibroblasts
|
N/A |
|
Recruiting
|
NCT03047369 -
The Myelin Disorders Biorepository Project
|
|
|
Active, not recruiting
|
NCT04658823 -
Efficacy and Safety of Tocotrienols in CADASIL
|
Phase 2 |
|
Withdrawn
|
NCT04334408 -
Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
|
Phase 2 |
|
Recruiting
|
NCT05734378 -
Prognosis of Cerebral Small Vessel Disease
|
|
|
Recruiting
|
NCT05491980 -
Florida Cerebrovascular Disease Biorepository and Genomics Center
|
|
|
Recruiting
|
NCT04036084 -
Development of New Biomarkers With Magnetic Resonance Imaging for Longitudinal Studies in CADASIL Angiopathy
|
|
|
Completed
|
NCT01865604 -
Impact of tDCS on Cerebral Autoregulation
|
N/A |